Events
ASCO 2022: Novel agent increases PFS for patients with the most common type of advanced breast cancer
- ASCO 2022: Biomarker guidance allows patients 55 or older with low-grade luminal A-type breast cancer to avoid radiation therapy
- ASCO 2022: Novel antibody-drug conjugate doubles progression-free survival in metastatic breast cancer with low HER2 expression levels
- ASCO 2022: Study offers guidance for future trials of adjuvant therapy for patients with early HR+/HER2- breast cancer
What can salad dressing tell us about cancer? Think oil and vinegar
Researchers led by St. Jude Children’s Research Hospital scientists have identified another way the process that causes oil to form…










